メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
並べ替え順
Keyphrases
Phosphorylation
100%
Gefitinib
100%
A549 Cells
100%
Erlotinib
100%
EIF2
100%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
100%
Cyclin D1 (CCND1)
66%
EIF2α Phosphorylation
50%
Interstitial Lung Disease
33%
Endoplasmic Reticulum Stress (ER stress)
33%
Cell Growth
33%
Concentration-dependent
16%
Kinase Activation
16%
Cell Death
16%
Cell Proliferation
16%
Growth Factor Receptor Tyrosine Kinase
16%
MRNA Expression
16%
Cytotoxicity
16%
Small Interfering RNA (siRNA)
16%
Intracellular Signaling
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Anticancer Agents
16%
Alveolar Epithelial Cells
16%
Lung Injury
16%
Activating Transcription Factor 4 (ATF4)
16%
Tauroursodeoxycholic Acid (TUDCA)
16%
Cell Repair
16%
C/EBP Homologous Protein
16%
Protein Kinase R-like Endoplasmic Reticulum Kinase
16%
Parkinson
16%
Disease-related Proteins
16%
Basal Epithelial Cells
16%
Repairable System
16%
Epidermal Growth Factor Receptor Inhibition
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Gefitinib
100%
Erlotinib
100%
Initiation Factor 2
100%
Initiation Factor 2alpha
100%
Cyclin D1
80%
Epidermal Growth Factor Receptor Kinase Inhibitor
80%
Interstitial Lung Disease
40%
Anticarcinogen
20%
Phosphotransferase
20%
Non Small Cell Lung Cancer
20%
Small Interfering RNA
20%
Tauroursodeoxycholic Acid
20%
Lung Injury
20%
Protein Kinase R
20%
Activating Transcription Factor 4
20%
Cytotoxicity
20%
Diseases
20%
Messenger RNA
20%